array(3) { ["company_details"]=> array(13) { ["name"]=> string(21) "Cardinal Health, Inc." ["slug"]=> string(28) "cb3e3-us-cardinal-health-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/1120e058-c420-4aa3-8c48-f09983914475" ["description"]=> string(1682) "Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world. We strive to be a trusted healthcare partner by driving growth in evolving areas of healthcare, while building upon our distribution, products, and solutions to meet customer needs. Disclaimer: LinkedIn is a third-party site unaffiliated with Cardinal Health. Cardinal Health is not responsible for the privacy or security policies or practices on LinkedIn or on any of the third-party websites that we may link to through LinkedIn. You should carefully review the privacy and security practices of LinkedIn and linked third-party websites. We do not necessarily endorse any information found here nor are we responsible for the accuracy of any information, opinions, claims, or advice found here or shared here by our followers. By posting content, ideas, or pictures, you grant Cardinal Health a non-exclusive, royalty-free, perpetual, and worldwide license to use your content and any images posted by you, including the rights to copy, distribute, transmit, display, reproduce, edit, translate, and reformat, and incorporate into a collective work. Cardinal Health reserves all rights relating to the company's LinkedIn account, including removing postings and prohibiting individuals from participating on the page." ["address_street"]=> string(16) "7000 Cardinal Pl" ["address_place"]=> string(6) "Dublin" ["address_region"]=> string(4) "Ohio" ["founding_date"]=> string(10) "1979-02-28" ["website_domain"]=> string(18) "cardinalhealth.com" ["website_url"]=> string(30) "https://www.cardinalhealth.com" ["industry_codes"]=> array(3) { [0]=> string(52) "Medical, Dental, and Hospital Equipment and Supplies" [1]=> string(50) "Drugs, Drug Proprietaries, and Druggists' Sundries" [2]=> string(19) "Management Services" } ["employee_count"]=> int(2800) ["article_count"]=> int(1124) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(53) "Cardinal Health details milestone year in biosimilars" ["snippet_en"]=> string(193) "In an annual report, the company revealed the impact of a dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability." ["url"]=> string(93) "https://www.ophthalmologytimes.com/view/cardinal-health-details-milestone-year-in-biosimilars" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7a6dfc7c-0d75-477f-a571-d7a0dc29f2e3" ["source"]=> string(22) "ophthalmologytimes.com" ["publication_date"]=> string(10) "2024-02-29" ["categories"]=> array(2) { [0]=> string(24) "Access and affordability" [1]=> string(24) "Quarterly/Annual Figures" } } [1]=> array(7) { ["title_en"]=> string(47) "Cardinal Health releases fiscal 2023 ESG report" ["snippet_en"]=> string(143) "Cardinal Health has reduced its Scope 1 and Scope 2 greenhouse gas emissions by 13%, making progress toward its fiscal 2030 50% reduction goal." ["url"]=> string(73) "https://drugstorenews.com/cardinal-health-releases-fiscal-2023-esg-report" ["image_url"]=> string(78) "https://images.businessradar.com/articles/deeb202f-c803-4ecc-82a9-3e5e7a52cccb" ["source"]=> string(17) "drugstorenews.com" ["publication_date"]=> string(10) "2024-02-06" ["categories"]=> array(3) { [0]=> string(13) "GHG Emissions" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(9) "Pollution" } } [2]=> array(7) { ["title_en"]=> string(61) "GE HealthCare (GEHC) Q4 Earnings Beat, Volume & Price Improve" ["snippet_en"]=> string(176) "GE HealthCare's (GEHC) fourth-quarter results benefit from continued demand for imaging, patient care and pharmaceutical diagnostic solutions. Sales gain from improved pricing." ["url"]=> string(45) "https://en.globes.co.il/en/article-1001469923" ["image_url"]=> string(78) "https://images.businessradar.com/articles/eb698f8b-ed17-454c-9a45-a5cce38385a7" ["source"]=> string(12) "globes.co.il" ["publication_date"]=> string(10) "2024-02-06" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [3]=> array(7) { ["title_en"]=> string(64) "Cardinal Health lowers medical unit profit forecast, shares fall" ["snippet_en"]=> string(197) "Cardinal Health lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and sending its shares down more than 5%." ["url"]=> string(135) "https://www.reuters.com/business/healthcare-pharmaceuticals/cardinal-health-lowers-medical-unit-profit-forecast-shares-fall-2024-02-01/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a19d2cbb-390c-4446-a9bf-927bbf4c8258" ["source"]=> string(11) "reuters.com" ["publication_date"]=> string(10) "2024-02-01" ["categories"]=> array(4) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(15) "Market Movement" [2]=> string(12) "Stock Market" [3]=> string(24) "Quarterly/Annual Figures" } } [4]=> array(7) { ["title_en"]=> string(60) "Cardinal Health (NYSE:CAH) Updates FY 2024 Earnings Guidance" ["snippet_en"]=> string(175) "Cardinal Health (NYSE:CAH) updated its FY 2024 earnings guidance. The company provided EPS guidance of 7.000-7.000 for the period, compared to the consensus estimate of 6.950." ["url"]=> string(80) "https://www.marketbeat.com/instant-alerts/nyse-cah-earnings-guidance-2024-01-09/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/bf72fe6e-02f9-4960-b8e6-44eb1898ce54" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-09" ["categories"]=> array(4) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Stock Research & Ratings" [2]=> string(24) "Quarterly/Annual Figures" [3]=> string(12) "Stock Market" } } [5]=> array(7) { ["title_en"]=> string(117) "Latest News Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2024 on February 1 - Businessfortnight" ["snippet_en"]=> string(226) "DUBLIN, Ohio, Jan. 2, 2024 /PRNewswire/ — Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1, prior to the opening of trading on the New York Stock Exchange." ["url"]=> string(116) "https://businessfortnight.com/cardinal-health-to-announce-second-quarter-results-for-fiscal-year-2024-on-february-1/" ["image_url"]=> NULL ["source"]=> string(21) "businessfortnight.com" ["publication_date"]=> string(10) "2024-01-02" ["categories"]=> array(8) { [0]=> string(24) "Access and affordability" [1]=> string(36) "Human Rights and Community Relations" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(12) "Staff hiring" [4]=> string(24) "Quarterly/Annual Figures" [5]=> string(7) "Opening" [6]=> string(14) "Product Launch" [7]=> string(12) "Stock Market" } } [6]=> array(7) { ["title_en"]=> string(96) "Cardinal Health Raises FY24 Non-GAAP EPS Guidance; Sees Pharmaceutical Revenue Growth Of 10%-12%" ["snippet_en"]=> string(279) "(RTTNews) - Cardinal Health (CAH) has raised its fiscal 2024 guidance range for non-GAAP earnings per share to $6.75 to $7.00, from prior guidance range of $6.50 to $6.75. The guidance includes an update to the Pharmaceutical segment profit outlook to 7% to 9% growth, from prior" ["url"]=> string(122) "https://www.nasdaq.com/articles/cardinal-health-raises-fy24-non-gaap-eps-guidance-sees-pharmaceutical-revenue-growth-of-10" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-11-03" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [7]=> array(7) { ["title_en"]=> string(31) "Cardinal Health raises forecast" ["snippet_en"]=> string(144) "Cardinal Health, the American health services group, published this Friday results for the first quarter of fiscal 2024 that were higher than..." ["url"]=> string(98) "https://www.boursier.com/actions/actualites/news/cardinal-health-releve-ses-previsions-912543.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/34fed904-ba6f-44ad-a45d-86771f6b86bf" ["source"]=> string(12) "boursier.com" ["publication_date"]=> string(10) "2023-11-01" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [8]=> array(7) { ["title_en"]=> string(17) "McKesson Earnings" ["snippet_en"]=> string(72) "McKesson earnings are on tap, with Cencora and Cardinal Health due soon." ["url"]=> string(101) "https://www.investors.com/news/mckesson-earnings-stealth-glp-1-weight-loss-drug-play-mckesson-rivals/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/6ff47432-3d65-40ca-a82c-3c370803b726" ["source"]=> string(13) "investors.com" ["publication_date"]=> string(10) "2023-11-01" ["categories"]=> array(6) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(6) "Outage" [3]=> string(11) "Name Change" [4]=> string(24) "Stock Research & Ratings" [5]=> string(12) "Stock Market" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(144) } [1]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(115) } [2]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(94) } [3]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(73) } [4]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(51) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(49) } [6]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(45) } [7]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(43) } [8]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(42) } [9]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(42) } [10]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(39) } [11]=> array(2) { ["name"]=> string(23) "Supply Chain Management" ["count"]=> int(38) } [12]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(34) } [13]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(33) } [14]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(32) } [15]=> array(2) { ["name"]=> string(14) "Product Recall" ["count"]=> int(26) } [16]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(25) } [17]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(25) } [18]=> array(2) { ["name"]=> string(23) "Supply Chain Disruption" ["count"]=> int(24) } [19]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(24) } [20]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(22) } [21]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(21) } [22]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(20) } [23]=> array(2) { ["name"]=> string(26) "Product Quality and safety" ["count"]=> int(20) } [24]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(20) } [25]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(20) } [26]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(18) } [27]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(16) } [28]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(14) } [29]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(13) } } } cb3e3-us-cardinal-health-inc